U.S., Aug. 13 -- ClinicalTrials.gov registry received information related to the study (NCT07116837) titled 'Perceived Effectiveness of Vaping Prevention Ads Among Adolescents and Young Adults' on Aug. 07.
Brief Summary: The purpose of the Aim 2 study is to assess the perceived effectiveness of vaping prevention ads among adolescents and young adults and identify which features of video ads predict perceived message effectiveness. Participants will include adolescents aged 13-17 and young adults aged 18-20 who live in the US and who are susceptible to vaping or who currently vape. In an online survey, participants will be randomized to view five randomly selected vaping prevention ads identified from a previous content analysis. After view...